Angiogenesis
Angiogenesis inhibitors are compounds that interfere with the formation of new blood vessels, a process critical in cancer growth and metastasis. By inhibiting angiogenesis, these compounds can restrict the blood supply to tumors, slowing or halting their growth. Angiogenesis inhibitors are essential in cancer research and therapeutic development, providing insights into the mechanisms of tumor progression and offering potential treatments for cancer and other angiogenesis-related diseases. At CymitQuimica, we offer a wide range of high-quality angiogenesis inhibitors to support your research in oncology and vascular biology.
Read more
Subcategories of "Angiogenesis"
Show 6 more subcategories
Products of "Angiogenesis"
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Bosutinib D8 REF: TM-T10583 | 98% | - - - | Discontinued product |
| CHMFL-FLT3-122 REF: TM-T27011CAS: 1839150-56-9 | 99.56% | - - - | Discontinued product |
| CHMFL-ABL-039 REF: TM-T10799CAS: 2304344-56-5 | 98.63% | - - - | Discontinued product |
Bosutinib D8
Bosutinib D8 is a deuterium-labeled Bosutinib. Bosutinib (SKI-606) is a dual Src/Abl inhibitor (IC50s: 1.2 …
Formula:
C26H21D8Cl2N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
538.5
Ref: TM-T10583
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
CHMFL-FLT3-122
CAS:1839150-56-9
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive …
Formula:
C26H29N7O2
Purity:
99.56%
Color and Shape:
Solid
Molecular weight:
471.55
Ref: TM-T27011
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
CHMFL-ABL-039
CAS:2304344-56-5
CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: …
Formula:
C31H33F3N6O3
Purity:
98.63%
Color and Shape:
Solid
Molecular weight:
594.63
Ref: TM-T10799
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 1ml*10 (DMSO) | Discontinued | Request information |
